Volatus Aerospace Appoints Lieutenant-General (Ret'd) Christopher J. Coates to Board of Advisors

Stock Information for Eupraxia Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Eupraxia Pharmaceuticals Inc.

Volatus Aerospace Releases Record Third Quarter Financial Results
Volatus Aerospace Closes $26,391,500 Bought Deal Public Offering and Non-Brokered Private Placement
Volatus Aerospace Announces Filing of Final Short Form Prospectus in Connection With Bought Deal Public Offering
Volatus Aerospace Inc. Announces Non-Brokered Private Placement of Up to $4.66 Million, Bringing Total Financing to Over $24.6 Million & Provides Corporate Update
VOLATUS AEROSPACE INC. ANNOUNCES $20 MILLION BOUGHT DEAL PUBLIC OFFERING
Volatus Aerospace Inc. Announces Restatement of Q2 2025 Financial Results
AI & Technology Virtual Investor Conference: Presentations Now Available for Online Viewing
Volatus Aerospace Acquires Strategic Dual-Use UAS Technology to Support Canada's Sovereign Capability and Allied Defense Requirements Worldwide

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.